{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:40:27Z","timestamp":1776822027182,"version":"3.51.2"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/WAB13\/UCSI\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/WAB13\/UCSI\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX113\\u201311114NI"],"award-info":[{"award-number":["NHRI-EX113\\u201311114NI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["114\\u20132320-B-002\\u2013009"],"award-info":[{"award-number":["114\\u20132320-B-002\\u2013009"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["114\\u20132320-B-002\\u2013028"],"award-info":[{"award-number":["114\\u20132320-B-002\\u2013028"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 113\\u20132320-B-002\\u2013001"],"award-info":[{"award-number":["MOST 113\\u20132320-B-002\\u2013001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031258","name":"UCSI University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118644","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:55:32Z","timestamp":1761130532000},"page":"118644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unravelling the role of cerebellar \u03b16GABAA receptors in anti-tremor pharmacotherapies"],"prefix":"10.1016","volume":"192","author":[{"given":"Ya-Hsien","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Yun","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Tatt","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7765-8171","authenticated-orcid":false,"given":"Chen-Jiun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-940X","authenticated-orcid":false,"given":"Lih-Chu","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118644_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2125.1985.tb05079.x","article-title":"The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment","volume":"20","author":"Abila","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118644_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109074","article-title":"Objective detection of microtremors in netrin-G2 knockout mice","volume":"351","author":"Ajima","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2025.118644_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12311-020-01106-w","article-title":"Anti-Tremor action of subtype selective positive allosteric modulators of GABA(A) receptors in a rat model of essential tremors","volume":"19","author":"Amrutkar","year":"2020","journal-title":"Cerebellum"},{"key":"10.1016\/j.biopha.2025.118644_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/bs.irn.2022.02.006","article-title":"Is essential tremor a disorder of GABA dysfunction? No","volume":"163","author":"Bellows","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118644_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020175","article-title":"The alpha6 GABA(A) receptor positive allosteric modulator DK-I-56-1 reduces Tic-Related behaviors in mouse models of tourette syndrome","volume":"11","author":"Cadeddu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118644_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1212\/WNL.47.2.557","article-title":"A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices","volume":"47","author":"Calabresi","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118344","article-title":"alpha6GABA(A) receptor positive allosteric modulators targeting trigeminal ganglia for preventing and aborting chronic periorbital allodynia and cephalic pain in both sexes: a mechanistic and comparative preclinical study","volume":"189","author":"Chang","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118644_bib8","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/bph.14198","article-title":"Cerebellar alpha(6) -subunit-containing GABA(A) receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders","volume":"175","author":"Chiou","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118644_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107613","article-title":"IUPHAR review: Alpha6-containing GABA(A) receptors - novel targets for the treatment of schizophrenia","volume":"213","author":"Chiou","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2025.118644_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0b013e3180d09969","article-title":"Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials","volume":"31","author":"Connor","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.biopha.2025.118644_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainres.2016.12.032","article-title":"Antiepileptic drugs prevent seizures in hyperbaric oxygen: a novel model of epileptiform activity","volume":"1657","author":"Demchenko","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2025.118644_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","article-title":"Treatment of patients with essential tremor","volume":"10","author":"Deuschl","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.118644_bib13","unstructured":"Dhaliwal J.S., Rosani A., Saadabadi A. 2025. Diazepam. In: (ed)^(eds). StatPearls, edn. Treasure Island (FL). p^pp."},{"key":"10.1016\/j.biopha.2025.118644_bib14","doi-asserted-by":"crossref","first-page":"1451634","DOI":"10.3389\/fphar.2024.1451634","article-title":"The deuterated pyrazoloquinolinone targeting alpha6 subunit-containing GABA(A) receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118644_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.07.017","article-title":"The alpha6 subunit-containing GABA(A) receptor: a novel drug target for inhibition of trigeminal activation","volume":"140","author":"Fan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118644_bib16","unstructured":"Franklin K.B.J., Paxinos G. 1997. The Mouse Brain in Stereotaxic Coordinates. edn. Academic Press."},{"key":"10.1016\/j.biopha.2025.118644_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5334\/tohm.229","article-title":"The GABA hypothesis in essential tremor: lights and shadows","volume":"4","author":"Gironell","year":"2014","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.biopha.2025.118644_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.irn.2022.02.005","article-title":"Is essential tremor a disorder of primary GABA dysfunction? Yes","volume":"163","author":"Gironell","year":"2022","journal-title":"Int Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118644_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.parkreldis.2012.04.024","article-title":"Gaba and serotonin molecular neuroimaging in essential tremor: a clinical correlation study","volume":"18","author":"Gironell","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biopha.2025.118644_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A randomized Placebo-Controlled comparative trial of gabapentin and propranolol in essential tremor","volume":"56","author":"Gironell","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2025.118644_bib21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/mds.22094","article-title":"Tiagabine for essential tremor: an open-label trial","volume":"23","author":"Gironell","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.118644_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1528-1157.2000.tb02167.x","article-title":"Differential sensitivity of recombinant GABA(A) receptors expressed in xenopus oocytes to modulation by topiramate","volume":"41","author":"Gordey","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2025.118644_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.seizure.2013.04.015","article-title":"Molecular mechanisms of antiseizure drug activity at GABAA receptors","volume":"22","author":"Greenfield","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.biopha.2025.118644_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2010.05.012","article-title":"T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor","volume":"59","author":"Handforth","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118644_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5334\/tohm.407","article-title":"Suppression of harmaline tremor by activation of an extrasynaptic GABAA receptor: implications for essential tremor","volume":"8","author":"Handforth","year":"2018","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.biopha.2025.118644_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5334\/tohm.407","article-title":"Suppression of harmaline tremor by activation of an extrasynaptic GABA(A) receptor: implications for essential tremor","volume":"8","author":"Handforth","year":"2018","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.biopha.2025.118644_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5334\/tohm.760","article-title":"Alcohol and ganaxolone suppress tremor via Extra-Synaptic GABA(A) receptors in the harmaline model of essential tremor","volume":"13","author":"Handforth","year":"2023","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.biopha.2025.118644_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12311-020-01197-5","article-title":"Increased purkinje cell complex spike and deep cerebellar nucleus synchrony as a potential basis for syndromic essential tremor. A review and synthesis of the literature","volume":"20","author":"Handforth","year":"2021","journal-title":"Cerebellum"},{"key":"10.1016\/j.biopha.2025.118644_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/JCNSD.S6561","article-title":"Pharmacotherapy of essential tremor","volume":"5","author":"Hedera","year":"2013","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.biopha.2025.118644_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.parkreldis.2015.05.005","article-title":"Testing for alcohol sensitivity of tremor amplitude in a large cohort with essential tremor","volume":"21","author":"Hopfner","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biopha.2025.118644_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S1461145707008346","article-title":"The synergistic inhibitory actions of oxcarbazepine on voltage-gated sodium and potassium currents in differentiated NG108-15 neuronal cells and model neurons","volume":"11","author":"Huang","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118644_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13311-023-01342-y","article-title":"Cerebellar alpha6GABA(A) receptors as a therapeutic target for essential tremor: Proof-of-Concept study with ethanol and pyrazoloquinolinones","volume":"20","author":"Huang","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.118644_bib33","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.7b01664","article-title":"Design and synthesis of novel deuterated ligands functionally selective for the \u03b3-aminobutyric acidtype A receptor (GABA(A)R) \u03b16 subtype with Improved metabolic stability and enhanced bioavailability","volume":"61","author":"Knutson","year":"2018","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118644_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.36.1.121","article-title":"Efficacy of primidone in essential tremor","volume":"36","author":"Koller","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib35","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020197","article-title":"GABA-A alpha 2\/3 but not alpha 1 receptor subunit ligand inhibits harmaline and Pimozide-Induced tremor in rats","volume":"13","author":"Kosmowska","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118644_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113022","article-title":"Targeting alpha6GABA(A) receptors as a novel therapy for schizophrenia: a proof-of-concept preclinical study using various animal models","volume":"150","author":"Lee","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118644_bib38","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s00213-016-4365-z","article-title":"Hispidulin alleviated methamphetamine-induced hyperlocomotion by acting at alpha6 subunit-containing GABAA receptors in the cerebellum","volume":"233","author":"Liao","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118644_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1212\/WNL.41.2_Part_1.234","article-title":"Essential tremor: clinical correlates in 350 patients","volume":"41","author":"Lou","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00002018-200326070-00003","article-title":"Benefits and risks of pharmacological treatments for essential tremor","volume":"26","author":"Lyons","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.biopha.2025.118644_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF01273153","article-title":"Change in the concentrations of amino acids in CSF and serum of patients with essential tremor","volume":"103","author":"M\u00e1lly","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2025.118644_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1468-1331.2008.02150.x","article-title":"A possible mechanism for the beneficial effect of ethanol in essential tremor","volume":"15","author":"Manto","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2025.118644_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mds.20331","article-title":"Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications","volume":"20","author":"Martin","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.118644_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/acn3.51943","article-title":"Objective response to ethanol in essential tremor: results from a standardized ethanol challenge study","volume":"11","author":"McGurrin","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2025.118644_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314912","article-title":"Alcohol withdrawal and the associated mood disorders-a review","volume":"23","author":"Ngui","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118644_bib46","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1016\/j.bmcl.2005.06.055","article-title":"Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides","volume":"15","author":"Nishimori","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118644_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ncl.2020.01.002","article-title":"Current and emerging treatments of essential tremor","volume":"38","author":"Ondo","year":"2020","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.biopha.2025.118644_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/bs.irn.2022.02.007","article-title":"Enhancing GABA inhibition is the next generation of medications for essential tremor","volume":"163","author":"Ondo","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118644_bib49","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15","author":"Ondo","year":"2000","journal-title":"Mov Disord."},{"key":"10.1016\/j.biopha.2025.118644_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/awr301","article-title":"Defective dentate nucleus GABA receptors in essential tremor","volume":"135","author":"Paris-Robidas","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.118644_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.05.031","article-title":"Pharmacological characterization of harmaline-induced tremor activity in mice","volume":"616","author":"Paterson","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118644_bib52","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1345\/aph.1H131","article-title":"Oxcarbazepine use in essential tremor","volume":"40","author":"Raj","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118644_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(80)90020-5","article-title":"Harmaline-induced tremor: the benzodiazepine receptor as a site of action","volume":"67","author":"Robertson","year":"1980","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118644_bib54","article-title":"Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action","volume":"35","author":"Schmutz","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2025.118644_bib55","doi-asserted-by":"crossref","first-page":"l4485","DOI":"10.1136\/bmj.l4485","article-title":"Essential tremor: diagnosis and management","volume":"366","author":"Shanker","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2025.118644_bib56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-4886(85)90193-1","article-title":"Further studies on quantification of drug-induced tremor in mice: effects of antitremorgenic agents on tremor frequency","volume":"88","author":"Shinozaki","year":"1985","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.118644_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pharmrev.121.000293","article-title":"alpha6-Containing GABA(A) receptors: functional roles and therapeutic potentials","volume":"74","author":"Sieghart","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2025.118644_bib58","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. Cvi: GABA(A) receptor Subtype- and Function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2025.118644_bib59","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","article-title":"Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies","volume":"15","author":"Simone","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118644_bib60","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1528-1157.1995.tb00958.x","article-title":"Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. Ii. modulation of High-Voltage-Activated calcium currents","volume":"36","author":"Stefani","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2025.118644_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000127841","article-title":"GABAergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia","volume":"82","author":"Stepanovic-Petrovic","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2025.118644_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","article-title":"Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex","volume":"12","author":"Suzuki","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biopha.2025.118644_bib63","doi-asserted-by":"crossref","first-page":"16142","DOI":"10.1523\/JNEUROSCI.2853-15.2015","article-title":"Ectopic expression of \u03b16 and \u03b4 GABAA receptor subunits in hilar somatostatin neurons increases tonic inhibition and alters network activity in the dentate gyrus","volume":"35","author":"Tong","year":"2015","journal-title":"J. Neurosci. Off. Jo. Soc. Neurosci."},{"key":"10.1016\/j.biopha.2025.118644_bib64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/WNL.0000000000207778","article-title":"The cerebellum as the central hub of a widespread network in essential tremor","volume":"101","author":"Trujillo","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13311-020-00951-1","article-title":"alpha6GABA(A) receptor positive modulators alleviate Migraine-like grimaces in mice via compensating GABAergic deficits in trigeminal ganglia","volume":"18","author":"Tzeng","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.118644_bib66","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ejp.1365","article-title":"Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of alpha6 GABA(A) receptors","volume":"23","author":"Vasovic","year":"2019","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.biopha.2025.118644_bib67","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1073\/pnas.2435171100","article-title":"Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type a receptors at low concentrations known to affect humans","volume":"100","author":"Wallner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118644_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1157.2000.tb02165.x","article-title":"Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism","volume":"41","author":"White","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2025.118644_bib69","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41386-021-00985-9","article-title":"Autistic-like behavior, spontaneous seizures, and increased neuronal excitability in a Scn8a mouse model","volume":"46","author":"Wong","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2025.118644_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eplepsyres.2005.10.001","article-title":"Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors","volume":"67","author":"Yoshida","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biopha.2025.118644_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ebiom.2019.03.008","article-title":"Gabapentin increases expression of \u03b4 subunit-containing GABA(A) receptors","volume":"42","author":"Yu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2025.118644_bib72","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-012-6628-x","article-title":"Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian movement disorders association","volume":"260","author":"Zappia","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2025.118644_bib73","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor [RETIRED]: report of the quality standards subcommittee of the American academy of neurology","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib74","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: treatment of essential tremor: report of the quality standards subcommittee of the American academy of neurology","volume":"77","author":"Zesiewicz","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.118644_bib75","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/mds.21559","article-title":"Tiagabine and exacerbation of essential tremor","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.118644_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40035-023-00391-9","article-title":"Supplementation with high-GABA-producing lactobacillus plantarum L5 ameliorates essential tremor triggered by decreased gut bacteria-derived GABA","volume":"12","author":"Zhong","year":"2023","journal-title":"Transl. Neurodegener."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:27:34Z","timestamp":1775780854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":76,"alternative-id":["S0753332225008388"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118644","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the role of cerebellar \u03b16GABAA receptors in anti-tremor pharmacotherapies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118644"}}